Showing results (81-90 of 188) with videos related to
Sort By:
Pageof 19
Cancer|April 7, 1998
Granulocyte-macrophage--colony stimulating factor in metastatic renal cell carcinoma: a phase II trialB I Rini, W M Stadler, R T Spielberger, et al.Cancer Research|March 15, 1993
Phase I clinical and pharmacological study of iododeoxyuridine and bleomycin in patients with advanced cancerR L Schilsky, L Janisch, F Berezin, et al.Cancer Research|July 15, 1994
Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrheaE Gupta, T M Lestingi, R Mick, et al.Cancer|August 3, 1999
A Phase I study of raltitrexed and paclitaxel given every 3 weeks to patients with solid tumorsE E Vokes, B C Goh, D Bertucci, et al.Cancer|December 18, 2001
Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors: a potential broadly active regimen for advanced solid tumor malignanciesS Mani, N J Vogelzang, D Bertucci, et al.Cancer Chemotherapy and Pharmacology|January 1, 1995
Encephalopathy is the dose-limiting toxicity of intravenous hepsulfam: results of a phase I trial in patients with advanced hematological malignanciesR A Larson, R B Geller, L Janisch, et al.Cancer|December 1, 1996
Mineralocorticoid insufficiency due to suramin therapyK Kobayashi, R E Weiss, N J Vogelzang, et al.Cancer Chemotherapy and Pharmacology|January 1, 1994
Sequential therapy with dacarbazine and carmustine: a phase I studyR B Mitchell, M E Dolan, L Janisch, et al.Seminars in Oncology|June 1, 1992
Laboratory and clinical studies of biochemical modulation by hydroxyureaR L Schilsky, M J Ratain, E E Vokes, et al.Clinical Pharmacology and Therapeutics|April 1, 1989
Pharmacokinetics and pharmacodynamics of long-term continuous-infusion doxorubicinS P Ackland, M J Ratain, N J Vogelzang, et al.Pageof 19